Pazopanib 400 mg · Strip

Pazib 400 Mg Tablet

Rx (Prescription Medicine)

USD $ 30.00

USD $ 1.00 per tablet

Upload prescription Ask about this medicine
  • Dispatched from licensed pharmacy partners
  • Tracked worldwide shipping
  • Secure payment

Pazib 400mg Tablet contains Pazopanib, a tyrosine kinase inhibitor used for advanced kidney cancer and soft tissue sarcoma. It works by inhibiting cancer cell growth and spread.

Key facts

Active ingredient
Pazopanib
Strength
400 mg
Form
Tablet
Drug class
Generic
Brand
Pazib
Manufacturer
Glenmark Pharmaceuticals
Pack sizes
30 Tablets

Description

Pazib 400mg Tablet is a medication containing Pazopanib, a tyrosine kinase inhibitor. It works by blocking the activity of certain proteins that are involved in the growth and spread of cancer cells. Pazopanib is primarily used to treat advanced renal cell carcinoma (kidney cancer) and advanced soft tissue sarcoma in adults who have previously received chemotherapy. The typical dosage is 800mg taken twice daily, with or without food. It is crucial to take Pazib 400mg Tablet exactly as prescribed by your doctor. Common side effects may include diarrhea, nausea, vomiting, fatigue, changes in hair color, and high blood pressure. Less common but serious side effects can occur, so it is important to report any unusual symptoms to your healthcare provider immediately. Store Pazib 400mg Tablet at room temperature, away from moisture and heat.

Additional information

Medicine Form

Tablet

Rx Status

Prescription Required

Medicine Type

Allopathy

Molecule

Pazopanib

Pack Quantity

30 Tablets

Strength

400mg

Brand Name

Molecule

Strength

400 mg

Medicine Form

Tablet

Pack Quantity

30 Tablets

Packaging Type

Strip

Medicine Type

Generic

Country Of Origin

India

Rx Status

Rx (Prescription Medicine)

Same molecule & strength

Other brands of Pazopanib 400 mg — the same active ingredient at the same strength, from a different manufacturer.

On this page
  1. Key facts
  2. Description
  3. Additional information
  4. Same molecule

Content integrity

Medically reviewed by

Renu Meena, B.Pharm

Medical Content Writer

Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Last reviewed 11/08/2026

Shipping to your country

Options
Fast Delivery – Arrives in 7–12 Days, Express shipping (Arriving in 3-7 days )
Free over
USD $ 200.00